ProCE Banner Activity

ExpressPoints Acclimating Practice to the Current Treatment Landscape in FL: Emerging Evidence and Recent Results

Slideset Download

Download this short summary slideset to review key takeaways from a live webinar where experts reviewed recent updates in the management of relapsed/refractory FL, including data from ASH 2022.

Released: February 16, 2023

Expiration: February 15, 2024

No longer available for credit.



Ian Flinn

Ian Flinn, MD, PhD

Chief Scientific Officer
Nashville, Tennessee

Laurie H. Sehn

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Genentech, a member of the Roche Group

MEI Pharma Inc